Therapeutic potential of α-santalol: Sources, mechanisms, and anti-tumor prospects
Fitoterapia · 2025
DOI: 10.1016/j.fitote.2025.106957 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Fitoterapia, 2025. Verfasst von Ruijun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Clinical Medical Research Center of Nervous System Diseases, Inner Mongolia Medical University, Hohhot 010050, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Antineoplastic Agents, Phytogenic, Neoplasms, Santalum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Inner Mongolia Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
Α-santalol, a naturally occurring sesquiterpene and a primary constituent of sandalwood oil, exhibits significant potential as an antitumor agent due to its diverse biological activities. Derived mainly from Santalum species like Santalum album, this compound has garnered attention for its profound effects on cancer prevention and treatment. Its anticancer properties are attributed to its ability to regulate cell cycle progression, induce apoptosis, and modulate key signaling pathways, including PI3K/Akt/mTOR and Wnt/β-catenin. Preclinical studies demonstrate α-santalol's efficacy in inhibiting various cancer cell lines such as breast, prostate, skin, and liver cancers, alongside its relatively lower toxicity to normal cells. In vitro and in vivo investigations reveal that α-santalol induces G2/M phase arrest, promotes apoptosis through intrinsic and extrinsic pathways, and suppresses tumor growth by targeting angiogenesis-related pathways. Furthermore, innovative delivery systems, such as chitosan nanoparticles, have enhanced its bioavailability, ensuring higher therapeutic efficacy with minimal systemic side effects. Studies on localized transdermal delivery also highlight its suitability for chemoprevention, particularly in high-risk cohorts. The synergistic potential of α-santalol when combined with other chemotherapeutic agents offers a promising avenue to reduce resistance mechanisms and enhance therapeutic outcomes. Nonetheless, challenges such as limited bioavailability and the need for robust clinical trials hinder its translation into standard care. Future research should prioritize optimizing delivery systems, designing well-structured clinical trials, and exploring interdisciplinary approaches for industrial scalability and applications in therapeutic and preventive oncology. α-santalol's potential in being an effective, low-toxicity, and sustainable cancer treatment underscores its value for further biomedical research and commercial development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inner Mongolia Clinical Medical Research Center of Nervous System Diseases, Inner Mongolia Medical University, Hohhot 010050, China.
- State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.
- State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China. Electronic address: yunling@jlu.edu.cn.
- Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China. Electronic address: peterfpan2020@mail.ccmu.edu.cn.
- Department of Neurosurgery, Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050, China. Electronic address: 49212552@qq.com.
Förderung
- National Natural Science Foundation of China
- Inner Mongolia Autonomous Region Natural Science Foundation
Zitieren
APA
Wang, R., Shi, G., Liu, Y., Pan, Y., & He, Z. (2025). Therapeutic potential of α-santalol: Sources, mechanisms, and anti-tumor prospects. Fitoterapia. https://doi.org/10.1016/j.fitote.2025.106957
Vancouver
Wang R, Shi G, Liu Y, Pan Y, He Z. Therapeutic potential of α-santalol: Sources, mechanisms, and anti-tumor prospects. Fitoterapia. 2025. doi:10.1016/j.fitote.2025.106957
BibTeX
@article{Wang2025,
author = {Wang, Ruijun and Shi, Guanyu and Liu, Yunling and Pan, Yuanming and He, Zhanbiao},
title = {Therapeutic potential of α-santalol: Sources, mechanisms, and anti-tumor prospects},
journal = {Fitoterapia},
year = {2025},
doi = {10.1016/j.fitote.2025.106957}
}
EUVIMED